BackChemomab Therapeutics Overview

Chemomab Therapeutics Operating Income

Operating Income for CMMB.

Quarterly Operating Income

$-1844985.00
↓ 47.09% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-7937315.00
↓ 24.08% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin